Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 14,446 | 13,015 | 12,807 | 10,003 | 8,720 |
| Cost of Goods | 3,469 | 5,836 | 4,506 | 4,561 | 3,652 |
| Gross Profit | 10,977 | 7,179 | 8,301 | 5,442 | 5,068 |
| Operating Expenses | 15,650 | 36,854 | 20,286 | 17,371 | 25,085 |
| Operating Income | -4,204 | -28,839 | -11,479 | -11,368 | -19,365 |
| Interest Expense | 3,936 | 4,273 | 4,273 | 4,276 | 4,278 |
| Other Income | 83 | 1,252 | 306 | 2,096 | 713 |
| Pre-tax Income | -8,057 | -31,860 | -15,446 | -13,548 | -22,930 |
| Net Income Continuous | -8,057 | -31,860 | -15,446 | -13,548 | -22,930 |
| Net Income | $-8,057 | $-31,860 | $-15,446 | $-13,548 | $-22,930 |
| EPS Basic Total Ops | -0.07 | -0.26 | -0.14 | -0.14 | -0.24 |
| EPS Basic Continuous Ops | -0.07 | -0.27 | -0.14 | -0.14 | -0.24 |
| EPS Diluted Total Ops | -0.07 | -0.26 | -0.14 | -0.14 | -0.24 |
| EPS Diluted Continuous Ops | -0.07 | -0.27 | -0.14 | -0.14 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.07 | -0.26 | -0.14 | -0.14 | -0.24 |
| EBITDA(a) | $-1,805 | $-25,960 | $-8,592 | $-8,480 | $-16,476 |